Study to Evaluate the Pharmacokinetics and Pharmacodynamics of AZD4604 Given Via the Turbuhaler® Device in Adults With Mild Asthma.

← catalyst calendar

NCT06732882

Sponsored by AstraZeneca (industry) · AZN — their whole pipeline →.

Phase

Phase 1

Status

Completed

Study type

Interventional

Design

Randomized · Quadruple · Treatment

Enrollment

28actual

Sites

Countries

Germany, United Kingdom

Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →

Source: ClinicalTrials.gov, retrieved 2026-08-19

Dates

each axis at the precision it was filed, with the registry's own basis

Date

Filed

Basis

What it is

Start

2025-02-27

actual

When the study began enrolling

Primary completion

2025-05-29

actual

The date the last participant is measured for the primary outcome — the readout window

Study completion

2025-05-29

actual

The whole study's end, after follow-up

First posted

2024-12-13

actual

When this record first appeared on the registry

Results posted

—

When the sponsor posted results to the registry

Record updated

2025-06-05

actual

The sponsor's own last edit to this record — every projection above is as current as this date

What it studies

Condition

Asthma

Interventions

Drug: AZD4604
Other: Placebo
Device: Genuair
Device: Turbuhaler